Influx Healthtech (NSE:INFLUX) Short Interest


NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
21 GF Score
Price ₹301.10
! 4 Warning Signs
View Full Analysis

What is Influx Healthtech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


NSE:INFLUX vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Influx Healthtech Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's Short Interest distribution charts can be found below:

* The bar in red indicates where Influx Healthtech's Short Interest falls into.


NSE:INFLUX
21GF Score
Influx Healthtech Ltd NSE:INFLUX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score

Get the complete analysis for NSE:INFLUX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹301.10
Price